Inactive Instrument

Presbia PLC

Equities

LENSF

IE00BJ0X7W22

Advanced Medical Equipment & Technology

Presbia plc Terminates Jake Vander Zanden as Chief Commercial Officer

April 30, 2015 at 11:27 am

On April 27, 2015, the employment of Jake Vander Zanden, Chief Commercial Officer of Presbia PLC was terminated. Mr. Vander Zanden is expected to provide transition services to the company through and including May 29, 2015.

Latest news about Presbia PLC

Presbia PLC(OTCPK:LENS.F) dropped from S&P TMI Index	29/04/19	CI
Presbia PLC Announces Management Changes	26/04/19	CI
Presbia PLC(OTCPK:LENS.F) dropped from NASDAQ Composite Index	24/04/19	CI
Presbia PLC Announces Executive Changes	22/04/19	CI
Presbia plc Reports Earnings Results for the Full Year Ended December 31, 2018	12/04/19	CI
Presbia PLC Auditor Raises 'Going Concern' Doubt	11/04/19	CI
Presbia PLC Announces Management Changes	01/02/19	CI
Presbia PLC announced that it has received $0.1 million in funding	09/12/18	CI
Presbia PLC announced that it has received $0.1 million in funding	11/04/18	CI
Presbia PLC Auditor Raises 'Going Concern' Doubt	29/03/18	CI
Presbia plc Announces the Resignation of Magda Michna as Chief Clinical Officer, Effective March 30, 2018	21/03/18	CI
Presbia PLC Announces Resignation of Vladimir Feingold from the Board of Directors	21/02/18	CI
Presbia PLC Announces New Management Appointments	13/02/18	CI
Presbia PLC Announces Management Changes	09/01/18	CI
Presbia PLC Announces Management Changes	14/12/17	CI
Presbia PLC Announces Management Changes	18/01/17	CI
Presbia PLC Provides Update on U.S. Staged Pivotal Clinical Trial	22/12/16	CI
Presbia Seeks Acqusitions	05/12/16	CI
Presbia PLC Appoints Jarett Fenton as Chief Financial Officer	16/06/16	CI
Presbia PLC Completes 6-Month Post-Operative Visits	31/05/16	CI
Presbia PLC Seeks Acquisition	15/04/16	CI
Presbia Announces First Patients in Presbia Microlens Fda Study Complete 12-Month Postoperative Visits	01/03/16	CI
Presbia PLC announces the Resignation of Richard Fogarty as Chief Accounting Officer, Vice President, Finance and Secretary, Effective March 31, 2016	12/02/16	CI
Presbia PLC Appoints Gerald Farrell, Ph.D. to Serve on the Board of Directors and as A Member of Audit Committee	20/01/16	CI
Presbia Introduces Time-Saving Disposable Microlens Inserter	05/10/15	CI

Chart Presbia PLC

Duration

Period

More charts

Company Profile

Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. It operates through the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. Its microlens is a disc-shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia. The Company's solution is intended primarily for emmetropic-presbyopes, or those individuals who suffer from presbyopia but do not have any other visual disorder. The Company has its manufacturing capacity in Irvine, California.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.61B

Other Advanced Medical Equipment & Technology